<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Screening tests of unproven benefit. In: Guidelines for preventive activities in general practice, 8th edition.&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Screening tests of unproven benefit. In: Guidelines for preventive activities in general practice, 8th edition. East Melbourne (Australia): Royal Australian College of General Practitioners; 2012. p. 85-6.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="ICD9CM: Abdominal aneurysm without mention of rupture  (441.4); Binocular vision disorder, unspecified  (368.30); Cardiovascular disease, unspecified  (429.2); Chronic airway obstruction, not elsewhere classified  (496); Colonoscopy  (45.23); Congestive heart failure, unspecified  (428.0); Electrocardiogram  (89.52); Heart failure, unspecified  (428.9); Malignant neoplasm of breast (female), unspecified  (174.9); Malignant neoplasm of bronchus and lung, unspecified  (162.9); Malignant neoplasm of colon, unspecified site  (153.9); Malignant neoplasm of ovary  (183.0); Malignant neoplasm of rectum  (154.1); Peripheral vascular disease, unspecified  (443.9); Unspecified disorder of thyroid  (246.9); Unspecified vitamin D deficiency  (268.9)"/><FieldValue Value="MSH: Ankle Brachial Index ; Aortic Aneurysm, Abdominal ; Bacteriuria ; Blood Chemical Analysis ; Breast Neoplasms ; C-Reactive Protein ; Cardiovascular Diseases ; Colonography, Computed Tomographic ; Colonoscopes ; Colonoscopy ; Colorectal Neoplasms ; Coronary Artery Disease ; Coronary Disease ; Culture Techniques ; Electrocardiography ; Exercise Test ; General Practice ; Genetic Diseases, Inborn ; Genetic Predisposition to Disease ; Genetic Testing ; Health Promotion ; Heart Failure ; Homocysteine ; Lung Neoplasms ; Magnetic Resonance Imaging ; Mass Screening ; Natriuretic Peptide, Brain ; Nutrition Assessment ; Ovarian Neoplasms ; Peripheral Vascular Diseases ; Positron-Emission Tomography ; Pregnancy Complications ; Preventive Health Services ; Primary Health Care ; Pulmonary Disease, Chronic Obstructive ; Spirometry ; Thyroid Diseases ; Thyroid Function Tests ; Tomography Scanners, X-Ray Computed ; Tomography, X-Ray Computed ; Ultrasonography ; Unnecessary Procedures ; Urinalysis ; Vision Disorders ; Vision Tests ; Vitamin D Deficiency "/><FieldValue Value="MTH: Ankle brachial pressure index (observable entity) ; Aortic Aneurysm, Abdominal ; Blood Chemical Analysis ; Brain natriuretic peptide measurement ; C-reactive protein ; C-reactive protein measurement ; CA 125 measurement ; Cardiovascular Diseases ; Chronic airway obstruction, NEC in ICD9CM_2014 ; Chronic Obstructive Airway Disease ; Colonoscopy ; Computed Tomographic Colonography ; Computed Tomography Scanning Systems ; Congestive heart failure ; Coronary Artery Disease ; Coronary heart disease ; Culture Techniques ; Electrocardiography ; Exercise stress test ; general practice (field) ; Genetic screening method ; Heart failure ; Hereditary Diseases ; homocysteine ; Homocysteine measurement ; Lung Neoplasms ; Magnetic Resonance Imaging ; Malignant neoplasm of female breast ; Malignant neoplasm of ovary ; Malignant Rectal Neoplasm ; Malignant tumor of colon ; Mammary Neoplasms ; Nesiritide ; Nutrition Assessment ; ovarian neoplasm ; Peripheral Vascular Diseases ; Plain chest X-ray ; Positron-Emission Tomography ; Pregnancy Complications ; Primary Health Care ; Spirometer (device) ; Thyroid Diseases ; Thyroid Function Tests ; Ultrasonography ; urinalysis ; Vision Disorders ; Vision Tests ; Vitamin D Deficiency ; X-Ray Computed Tomography "/><FieldValue Value="PDQ: colonoscopy ; computed tomography ; magnetic resonance imaging ; nesiritide ; ultrasonography ; virtual colonoscopy "/><FieldValue Value="SNOMEDCT_US: Abdominal aortic aneurysm  (233985008); Abdominal aortic aneurysm without rupture  (75878002); Ankle brachial pressure index  (446841001); Assessment of nutritional status  (1759002); Assessment of nutritional status  (310243009); Asymptomatic bacteriuria  (236704009); Bacteriuria  (61373006); Binocular vision disorder  (83275001); Blood chemistry  (166312007); Brain natriuretic peptide measurement  (390917008); C reactive protein  (61425002); C-reactive protein measurement  (55235003); CA 125 measurement  (80529009); Chronic obstructive pulmonary disease finding  (13645005); Chronic obstructive pulmonary disease finding  (413846005); Colonoscope  (90412006); Colonoscopy  (73761001); Computerized axial tomography  (77477000); Congestive heart failure  (42343007); Disorder of cardiovascular system  (49601007); Disorder of coronary artery  (414024009); Disorder of thyroid gland  (14304000); Disorder of vision  (128127008); Disorder of vision  (95677002); Electrocardiographic procedure  (29303009); Exercise tolerance test  (165079009); General medicine  (394802001); Genetic predisposition  (47708004); Genetic test  (405824009); Health promotion  (171434007); Heart failure  (84114007); Hereditary disease  (32895009); Homocysteine  (102747008); Homocysteine measurement  (104733005); Magnetic resonance imaging  (113091000); Magnetic resonance imaging  (312250003); Magnetic resonance imaging unit  (90003000); Malignant neoplasm of female breast  (372064008); Malignant tumor of colon  (363406005); Malignant tumor of ovary  (363443007); Malignant tumor of rectum  (363351006); Neoplasm of breast  (126926005); Neoplasm of large intestine  (126837005); Neoplasm of lung  (126713003); Neoplasm of ovary  (123843001); Nesiritide  (385678006); Nesiritide  (385679003); Nesiritide  (385680000); Nesiritide  (407059007); Peripheral vascular disease  (400047006); Plain chest X-ray  (399208008); Positron emission tomography  (363678002); Positron emission tomography  (82918005); Positron emission tomography unit  (39821008); Positron emission tomography unit  (462323006); Spirometer  (303501006); Spirometry  (127783003); Thyroid panel  (35650009); Transvaginal ultrasonography of pelvis  (429915000); Ultrasonography  (16310003); Ultrasonography  (278292003); Ultrasonography  (359659005); Urinalysis  (167217005); Urinalysis  (27171005); Urine for culture  (117010004); Urine for culture  (275885001); Visual testing  (268360001); Vitamin D deficiency  (34713006)"/><FieldValue Value="SPN: COLONOSCOPE, GENERAL & PLASTIC SURGERY ; SYSTEM, IMAGING, PULSED DOPPLER, ULTRASONIC ; SYSTEM, NUCLEAR MAGNETIC RESONANCE IMAGING ; SYSTEM, TOMOGRAPHY, COMPUTED, EMISSION ; SYSTEM, X-RAY, TOMOGRAPHY, COMPUTED "/><FieldValue Value="UMD: Colonoscopes  (10-950); Physiologic Monitor Modules, Electrocardiography  (20-771); Radiographic Systems  (18-429); Scanning Systems, Computed Tomography  (13-469); Scanning Systems, Magnetic Resonance Imaging  (16-260); Scanning Systems, Magnetic Resonance Imaging, Mammographic  (18-110); Scanning Systems, Positron Emission Tomography  (16-375); Scanning Systems, Ultrasonic  (14-278); Scanning Systems, Ultrasonic, Abdominal  (16-241); Spirometers  (13-674)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Genetic disorders &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Coronary heart disease &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cardiovascular disease &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Peripheral vascular disease &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Abdominal aneurysm &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Congestive cardiac failure &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Breast cancer &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Ovarian cancer &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Colorectal cancer &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Lung cancer &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Chronic obstructive pulmonary disease &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Thyroid dysfunction &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Vitamin D deficiency, including deficiency in pregnancy &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Asymptomatic bacteriuria &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Visual impairment &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Prevention" /><FieldValue Value="Screening" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Cardiology" /><FieldValue Value="Endocrinology" /><FieldValue Value="Family Practice" /><FieldValue Value="Geriatrics" /><FieldValue Value="Medical Genetics" /><FieldValue Value="Obstetrics and Gynecology" /><FieldValue Value="Oncology" /><FieldValue Value="Ophthalmology" /><FieldValue Value="Optometry" /><FieldValue Value="Preventive Medicine" /><FieldValue Value="Pulmonary Medicine" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Advanced Practice Nurses" /><FieldValue Value="Health Care Providers" /><FieldValue Value="Nurses" /><FieldValue Value="Physician Assistants" /><FieldValue Value="Physicians" /><FieldValue Value="Public Health Departments" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;To provide a comprehensive and concise set of recommendations for patients in general practice with additional information about tailoring risk and need &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To provide the evidence base for which primary healthcare resources can be used efficiently and effectively while providing a rational basis to ensure the best use of time and resources in general practice &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Low-risk general practice populations in Australia, including pregnant women and the elderly&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Genetic profiling for genetic disorders &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cardiac computed tomography (CT) for coronary heart disease (CHD) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Serum homocysteine measurement for CHD &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Exercise electrocardiography (ECG) for CHD &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;High-sensitivity C-reactive protein (CRP) for cardiovascular disease (CVD) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Ankle:brachial index (ABI) for peripheral vascular disease &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Magnetic resonance imaging (MRI) for breast cancer &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cancer antigen (CA) 125 and transvaginal ultrasound for ovarian cancer &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Virtual colonoscopy/CT colonography for colorectal cancer &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Whole body CT or MRI for cancer &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Chest CT for lung cancer &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Positron emission tomography (PET)-CT for lung cancer &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Spirometry for chronic obstructive pulmonary disease (COPD) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Thyroid function tests for thyroid dysfunction &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Screening for vitamin D deficiency &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Midstream urine culture for asymptomatic bacteriuria in the elderly &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Screening for visual impairment in the elderly &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Ultrasound for abdominal aneurysm &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;B-type natriuretic peptide (BNP) for congestive cardiac failure &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: None of the tests are recommended as screening tests in low-risk general practice populations. These tests may have value as diagnostic tests or as tests to monitor disease progression.&lt;/p&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Sensitivity and specificity of screening tests &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Prognostic value and diagnostic yield of screening tests &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;False-positive and false-negative results &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Benefits and harms of screening tests &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Quality of life &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Mortality &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Hand-searches of Published Literature (Primary Sources)" /><FieldValue Value="Hand-searches of Published Literature (Secondary Sources)" /><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Sources of Recommendations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The recommendations in these guidelines are based on current, evidence-based guidelines for preventive activities. The Taskforce focused on those most relevant to Australian general practice. Usually this means that the recommendations are based on Australian guidelines such as those endorsed by the National Health and Medical Research Council (NHMRC).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;In cases where these are not available or recent, other Australian sources have been used, such as guidelines from the Heart Foundation, Canadian or United States preventive guidelines, or the results of systematic reviews. References to support these recommendations are listed. However, particular references may relate to only part of the recommendation (e.g., only relating to one of the high-risk groups listed) and other references in the section may have been considered in formulating the overall recommendation.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Levels of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Levels of Evidence&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Level&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Explanation&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;I&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Evidence obtained from a systematic review of level II studies&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;II&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Evidence obtained from a randomised controlled trial (RCT)&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;III&amp;ndash;1&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Evidence obtained from a pseudo-randomised controlled trial (i.e., alternate allocation or some other method)&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;III&amp;ndash;2&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Evidence obtained from a comparative study with concurrent controls:&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Non-randomised, experimental trial &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Cohort study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Case&amp;ndash;control study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Interrupted time series with a control group &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;III&amp;ndash;3&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Evidence obtained from a comparative study without concurrent controls:&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Historical control study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Two or more single arm study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Interrupted time series without a parallel control group &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;IV&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Case series with either post-test or pre-test/post-test outcomes&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practice Point&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Opinions of respected authorities, based on clinical experience, descriptive studies or reports of expert committees&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Review of Published Meta-Analyses" /><FieldValue Value="Systematic Review" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;These &lt;em&gt;Guidelines for preventive activities in general practice&lt;/em&gt;, 8th edition, have been developed by a taskforce of general practitioners (GPs) and experts to ensure that the content is the most valuable and useful for GPs and their teams. The guidelines provide an easy, practical and succinct resource. The content broadly conforms to the highest evidence-based standards according to the principles underlying the Appraisal of Guidelines Research and Evaluation.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The dimensions addressed are:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Scope and purpose &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Clarity of presentation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Rigour of development &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Stakeholder involvement &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Applicability &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Editorial independence &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;The Red Book maintains developmental rigour, editorial independence, relevance and applicability to general practice.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Screening Principles&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The World Health Organization (WHO) has produced guidelines for the effectiveness of screening programs. The Taskforce has kept these and the United Kingdom National Health Services' guidelines in mind in the development of recommendations about screening and preventive care.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Grades of Recommendations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Grades of Recommendations&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Grade&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Explanation&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Body of evidence can be trusted to guide practice&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;B&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Body of evidence can be trusted to guide practice in most situations&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;C&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Body of evidence provides some support for recommendation(s) but care should be taken in its application&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;D&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Body of evidence is weak and recommendation must be applied with caution&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A formal cost analysis was not performed and published cost analyses were not reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following are not recommended as screening tests in low-risk general practice populations. These tests may have value as diagnostic tests or as tests to monitor disease progression.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Screening Tests of Unproven Benefit&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Screening Tests Not Recommended in Low-risk General Practice Populations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Screening Tests Not Recommended in Low-risk General Practice Populations&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Screening Test&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Condition&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Reason Not to Use&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;References for Further Reading&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Genetic profiling&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Genetic disorders&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Limited evidence on the balance of benefits and harms, ethical issues and uncertain utility.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Udesky, 2010; Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group, 2010&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;4&quot;&gt;&lt;em&gt;Vascular&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Cardiac computerised tomography (CT)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Coronary heart disease (CHD)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;No randomised controlled trial (RCT) evidence. RCTs of therapy show no effect on coronary artery progression. May be of benefit in those at intermediate risk of CHD.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Taylor et al., 2010; McEvoy et al., 2010; US Preventive Services Task Force (USPSTF), &quot;Using,&quot; 2009&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Serum homocysteine&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;CHD&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Value as a risk factor for CHD is uncertain and published RCTs show no evidence of benefit by lowering levels.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;USPSTF, &quot;Using,&quot; 2009; Loland et al., 2010; Potter, Lenzo, &amp;amp; Eikelboom, 2009&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Exercise electrocardiograph (ECG)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;CHD&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Low yield and high false positive rate given low prevalence in asymptomatic population.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;USPSTF, &quot;Using,&quot; 2009; Lim et al., 2011&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;High sensitivity C-reactive protein (CRP)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Cardiovascular disease (CVD)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Some evidence of benefit (i.e., reduction in CRP linked with reduction in major CVD events in one study, but not currently recommended as a screening test for CVD).&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;USPSTF, &quot;Using,&quot; 2009; Lim et al., 2011; Helfand et al., 2009; Genest et al., 2009; Buckley et al., 2009; Kones, 2009&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Ankle:brachial index (ABI)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Peripheral vascular disease&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Longitudinal studies showing increased risk of clinical CVD if low ABI, but there is variable reliability and low sensitivity of assessment and no published RCT evidence showing benefit of screening.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Helfand et al., 2009; Grondal et al., 2010; Ankle Brachial Index Collaboration et al., 2008&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;4&quot;&gt;&lt;em&gt;Cancer&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Magnetic resonance imaging (MRI)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Breast cancer&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Ongoing surveillance strategies for women at high risk of breast cancer may include imaging with MRI. A Medicare rebate is available for MRI scans for asymptomatic women under 50 years at high risk of breast cancer.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;National Breast and Ovarian Cancer Centre (NBOCC), &quot;Early detection,&quot; 2009; NBOCC, 2010; National Breast Cancer Centre (NBCC), 2006; USPSTF, &quot;Screening for breast cancer,&quot; 2009; Australian Department of Health and Ageing, 2012&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Cancer antigen (CA)125/transvaginal ultrasound&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Ovarian cancer&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;There is no evidence to support the use of any test &amp;ndash; including pelvic examination, CA125, or other biomarkers, ultrasound (including transvaginal ultrasound), or combination of tests &amp;ndash; for routine population-based screening for ovarian cancer. &lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            CA125 is limited by poor sensitivity in early-stage disease and low specificity. The specificity of transvaginal ultrasound is low. The low prevalence of ovarian cancer means that even screening tests that have very high sensitivity and specificity have a low positive predictive value for disease detection.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Schorge et al., 2010; NBOCC, &quot;Population screening,&quot; 2009&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Virtual colonoscopy/CT colonography&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Colorectal cancer (CRC)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Good sensitivity for lesions larger than 10 mm, but no evidence of reduction of CRC incidence or mortality. Not currently recommended.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Zauber et al., 2009; Philip, Lubner, &amp;amp; Harms, 2011; Weizman &amp;amp; Nguyen, 2010; Pox &amp;amp; Schmiegel, 2010; Laghi et al., 2010; Lieberman, 2009&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Whole body CT or MRI&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Cancer&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Whole body imaging has not been shown to improve quality of life and/or decrease mortality. It is associated with additional radiation exposure and a high number of false positive results. There are no RCTs of whole body imaging to detect cancer or CVD.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Weltermann, Hermann, &amp;amp; Gesenhues, 2010; Canadian Health Services Research Foundation, 2010; Ladd, 2009; Fayngersh &amp;amp; Passero, 2009; Schoder &amp;amp; Gonen, 2007; Anderiesz et al., 2004&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;4&quot;&gt;&lt;em&gt;Lung Disease&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Spirometry&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Chronic obstructive pulmonary disease (COPD)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Assessment is unreliable and screening for COPD using spirometry has no net benefit.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;O'Reilly &amp;amp; Rudolf, 2011; COPD Guidelines Committee, 2011; &quot;Screening for chronic,&quot; 2009; O'Donnell et al., 2008&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;4&quot;&gt;&lt;em&gt;Endocrine&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Thyroid function tests&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Thyroid dysfunction&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Despite the relatively high incidence of subclinical hypothyroidism in older women (up to 17%), there is a lack of convincing data from controlled trials that early treatment reduces lipid levels, symptoms or the risk for CVD in patients with mild thyroid dysfunction detected by screening.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Gopinath et al., 2010; Ochs et al., 2008; Empson et al., 2007; Helfand, 2004&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;4&quot;&gt;&lt;em&gt;Chronic Disease Prevention&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Vitamin D&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Vitamin D deficiency&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;High prevalence, variability in assessment and lack of rigorous evidence of benefit of screening.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Bjelakovic et al., 2011; Chung et al., 2010; Hanley et al., 2010; Holick et al., 2011; Wang et al., 2010&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;4&quot;&gt;&lt;em&gt;Infection&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Midstream urine (MSU) culture&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Asymptomatic bacteriuria (elderly)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Identifying and treating non-pregnant adults with asymptomatic bacteriuria does not improve outcomes and may increase antibiotic resistance.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Lin, Fajardo &amp;amp; USPSTF, 2008&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Screening Tests of Indeterminate Value&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Screening Tests of Indeterminate Value&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Screening Test&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Condition&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Reason Not to Use&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;References&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;4&quot;&gt;&lt;em&gt;Women&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Vitamin D&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Pregnancy&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Moderate prevalence and associated morbidity, but no randomised controlled trial (RCT) evidence of benefit. There is debate about what is an adequate level of vitamin D. High-risk groups for vitamin D deficiency may benefit from screening and supplementation.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Ebeling, 2011; Dror &amp;amp; Allen, 2010; Lichtenstein, 2009; Holmes, et al., 2009&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;4&quot;&gt;&lt;em&gt;Vascular&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Ultrasound&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Abdominal aneurysm&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;USPSTF recommend screening, but low yield as declining incidence and ethical issues of screening only one subgroup (male smokers), and cost-effectiveness not clear.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Aggarwal et al., 2011; Ferket et al., 2012; &quot;Screening,&quot; 2005&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;B-type natriuretic peptide (BNP)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Congestive cardiac failure&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;The evidence for screening for heart failure using BNP is mixed despite its sensitivity and prognostic significance. It may be useful in excluding the condition in suspected heart failure.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Felker et al., 2009; Krum et al., 2011; National Institute for Health and Clinical Excellence, 2010; Porapakkham et al., 2010&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;4&quot;&gt;&lt;em&gt;Cancer&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Chest computerised tomography (CT)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Lung cancer&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Good sensitivity but poor specificity; one RCT underway in smokers has preliminary results showing a 20% reduction in mortality in the CT arm. Low-dose CT screening may benefit individuals at an increased risk for lung cancer, but uncertainty exists about the potential harms of screening and the generalisability of results. Approximately 20% of individuals in each round of screening had positive results requiring some degree of follow-up, while approximately 1% had lung cancer.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Mulshine &amp;amp; van Klaveren, 2011; Baldwin, 2011; Bach et al., 2012&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Positron emission tomography (PET) &amp;ndash; CT (or PET CT scan)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Lung cancer&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Good sensitivity and specificity, but no RCT results.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Baldwin, 2011&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;4&quot;&gt;&lt;em&gt;Elderly&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Visual acuity&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Visual impairment&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;No benefits of screening, even though impaired visual acuity is common and effective treatments are available.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Smeeth &amp;amp; Iliffe, 2006; Chou, Dana, &amp;amp; Bougatsos, 2009&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None provided&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="98" OrdBy="605" ID="425" Name="References Supporting the Recommendations" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Aggarwal S, Qamar A, Sharma V, Sharma A. Abdominal aortic aneurysm: A comprehensive review. Exp Clin Cardiol. 2011 Spring;16(1):11-5. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21523201&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Anderiesz C, Elwood JM, McAvoy BR, Kenny LM. Whole-body computed tomography screening: looking for trouble. Med J Aust. 2004 Sep 20;181(6):295-6. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15377236&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FG, Lee AJ, Price JF, d'Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodriguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CD, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hedblad B, Witteman JC, Breteler MM, Hunink MG, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J, McDermott MM. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008 Jul 9;300(2):197-208. [48 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18612117&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Australian Department of Health and Ageing. MBS Online - medicare benefits schedule. [internet]. [accessed 2012 Jun 01]. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012 Jun 13;307(22):2418-29. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22610500&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Baldwin DR. Imaging in lung cancer: recent advances in PET-CT and screening. Thorax. 2011 Apr;66(4):275-7. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21422043&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2011;(7):CD007470. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21735411&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med. 2009 Oct 6;151(7):483-95. [98 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19805771&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Canadian Health Services Research Foundation. Myth: whole-body screening is an effective way to detect hidden cancers. J Health Serv Res Policy. 2010 Apr;15(2):118-9. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20339153&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Chou R, Dana T, Bougatsos C. Screening older adults for impaired visual acuity: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2009 Jul 7;151(1):44-58, W11-20. [91 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19581646&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Chung M, Balk EM, Ip S, Lee J, Terasawa T, Raman G, Trikalinos T, Lichtenstein AH, Lau J. Systematic review to support the development of nutrient reference intake values: challenges and solutions. Am J Clin Nutr. 2010 Aug;92(2):273-6. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20504974&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;COPD Guidelines Committee. The COPD-X: Australian and New Zealand Guidelines for the managment of chronic obstructive pulmonary disease. Canberra: Australian Lung Foundation and the Thoracic Society of Australia and New Zealand; 2011. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Dror DK, Allen LH. Vitamin D inadequacy in pregnancy: biology, outcomes, and interventions. Nutr Rev. 2010 Aug;68(8):465-77. [127 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20646224&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Ebeling PR. Routine screening for vitamin D deficiency in early pregnancy: past its due date. Med J Aust. 2011 Apr 4;194(7):332-3. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21470080&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Empson M, Flood V, Ma G, Eastman CJ, Mitchell P. Prevalence of thyroid disease in an older Australian population. Intern Med J. 2007 Jul;37(7):448-55. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17547723&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: genomic profiling to assess cardiovascular risk to improve cardiovascular health. Genet Med. 2010 Dec;12(12):839-43. [18 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21042222&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Fayngersh V, Passero M. Estimating radiation risk from computed tomography scanning. Lung. 2009 May-Jun;187(3):143-8. [51 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19350325&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Felker GM, Hasselblad V, Hernandez AF, O'Connor CM. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized  controlled trials. Am Heart J. 2009 Sep;158(3):422-30. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19699866&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Ferket BS, Grootenboer N, Colkesen EB, Visser JJ, van Sambeek MR, Spronk S, Steyerberg EW, Hunink MG. Systematic review of guidelines on abdominal aortic aneurysm screening. J Vasc Surg. 2012 May;55(5):1296-1304. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21324630&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, Couture P, Dufour R, Fodor G, Francis GA, Grover S, Gupta M, Hegele RA, Lau DC, Leiter L, Lewis GF, Lonn E, Mancini GB, Ng D, Pearson GJ, Sniderman A, Stone JA, Ur E. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol. 2009 Oct;25(10):567-79. [79 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19812802&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Gopinath B, Wang JJ, Kifley A, Wall JR, Eastman CJ, Leeder SR, Mitchell P. Five-year incidence and progression of thyroid dysfunction in an older population. Intern Med J. 2010 Sep;40(9):642-9. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20840213&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Grondal N, Sogaard R, Henneberg EW, Lindholt JS. The Viborg Vascular (VIVA) screening trial of 65-74 year old men in the central region of Denmark: study protocol. Trials. 2010;11:67. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20507582&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD, Guidelines Committee of the Scientific Advisory Council of Osteoporosis Canada. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary). CMAJ. 2010 Sep 7;182(12):1315-9. [51 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20624865&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C, Humphrey LL. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med. 2009 Oct 6;151(7):496-507. [212 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19805772&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Helfand M. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004 Jan 20;140(2):128-41. [87 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14734337&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30. [143 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21646368&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Holmes VA, Barnes MS, Alexander HD, McFaul P, Wallace JM. Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study. Br J Nutr. 2009 Sep;102(6):876-81. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19331703&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Kones R. The Jupiter study, CRP screening, and aggressive statin therapy-implications for  the primary prevention of cardiovascular disease. Ther Adv Cardiovasc Dis. 2009 Aug;3(4):309-15. [41 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19460829&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Krum H, Jelinek MV, Stewart S, Sindone A, Atherton JJ, National Heart Foundation of Australia, Cardiac Society of Australia and New Zealand. 2011 update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006. Med J Aust. 2011 Apr 18;194(8):405-9. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21495941&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Ladd SC. Whole-body MRI as a screening tool. Eur J Radiol. 2009 Jun;70(3):452-62. [75 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19345540&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Laghi A, Iafrate F, Rengo M, Hassan C. Colorectal cancer screening: the role of CT colonography. World J Gastroenterol. 2010 Aug 28;16(32):3987-94. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20731011&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Lichtenstein AH. Nutrient supplements and cardiovascular disease: a heartbreaking story. J Lipid Res. 2009 Apr;50(Suppl):S429-33. [69 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18997166&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Lieberman DA. Clinical practice. Screening for colorectal cancer. N Engl J Med. 2009 Sep 17;361(12):1179-87. [55 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19759380&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Lim LS, Haq N, Mahmood S, Hoeksema L, ACPM Prevention Practice Committee, American College of Preventive Medicine. Atherosclerotic cardiovascular disease screening in adults: American College of Preventive Medicine position statement on preventive practice. Am J Prev Med. 2011 Mar;40(3):381.e1-10. [55 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21335273&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Lin K, Fajardo K, U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008 Jul 1;149(1):W20-4. [9 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18591632&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Loland KH, Bleie O, Blix AJ, Strand E, Ueland PM, Refsum H, Ebbing M, Nordrehaug JE, Nygard O. Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy. Am J Cardiol. 2010 Jun 1;105(11):1577-84. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20494665&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;McEvoy JW, Blaha MJ, Defilippis AP, Budoff MJ, Nasir K, Blumenthal RS, Jones SR. Coronary artery calcium progression: an important clinical measurement? A review  of published reports. J Am Coll Cardiol. 2010 Nov 9;56(20):1613-22. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21050970&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Mulshine JL, van Klaveren RJ. Lung cancer screening: what is the benefit and what do we do about it. Lung Cancer. 2011 Mar;71(3):247-8. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21277040&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;National Breast and Ovarian Cancer Centre (NBOCC). Advice about familial aspects of breast and epithelial ovarian cancer: a guide for health professionals. Sydney: National Breast and Ovarian Cancer Centre (NBOCC); 2010. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;National Breast and Ovarian Cancer Centre. Early detection of breast cancer - NBOCC position statement. [internet]. Sydney: National Breast and Ovarian Cancer Centre (NBOCC); 2009&amp;nbsp;[accessed 2012 May 01]. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;National Breast and Ovarian Cancer Centre. Population screening and early detection of ovarian cancer in asymptomatic women - NBOCC position statement. [internet]. 2009&amp;nbsp;[accessed 2012 May 01]. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;National Breast Cancer Centre (NBCC). Magnetic resonance imaging for the early detection of breast cancer in women at high risk: a systematic review of evidence. Sydney: National Breast Cancer Centre (NBCC); 2006. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;National Institute for Health and Clinical Excellence (NICE). Chronic heart failure. National clinical guideline for diagnosis and management in primary and secondary care. London: National Institute for Health and Clinical Excellence (NICE); 2010. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, Rodondi N. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008 Jun 3;148(11):832-45. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18490668&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;O'Donnell DE, Hernandez P, Kaplan A, Aaron S, Bourbeau J, Marciniuk D, Balter M, Ford G, Gervais A, Lacasse Y, Maltais F, Road J, Rocker G, Sin D, Sinuff T, Voduc N. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J. 2008 Jan-Feb;15(Suppl A):1A-8A. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18292855&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;O'Reilly J, Rudolf M. What's nice about the new NICE guideline. Thorax. 2011 Feb;66(2):93-6. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21097818&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Philip AK, Lubner MG, Harms B. Computed tomographic colonography. Surg Clin North Am. 2011 Feb;91(1):127-39. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21184904&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Porapakkham P, Porapakkham P, Zimmet H, Billah B, Krum H. B-type natriuretic peptide-guided heart failure therapy: A meta-analysis. Arch Intern Med. 2010 Mar 22;170(6):507-14. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20308637&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Potter K, Lenzo N, Eikelboom JW, Arnolda LF, Beer C, Hankey GJ. Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial. Cerebrovasc Dis. 2009;27(3):259-65. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19202330&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Pox CP, Schmiegel W. Role of CT colonography in colorectal cancer screening: risks and benefits. Gut. 2010 May;59(5):692-700. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20427403&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Schoder H, Gonen M. Screening for cancer with PET and PET/CT: potential and limitations. J Nucl Med. 2007 Jan;48(Suppl 1):4S-18S. [114 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17204716&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Schorge JO, Modesitt SC, Coleman RL, Cohn DE, Kauff ND, Duska LR, Herzog TJ. SGO white paper on ovarian Cancer: Etiology, screening and surveillance. Gynecol Oncol. 2010 Oct;119(1):7-18. [116 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20692025&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med. 2005 Feb 1;142(3):198-202. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15684208&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Screening for chronic obstructive pulmonary disease using spirometry: recommendation statement. Am Fam Physician. 2009 Oct 15;80(8):853. [1 reference] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19835346&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Smeeth L, Iliffe S. Community screening for visual impairment in the elderly. Cochrane Database Syst Rev. 2006;(3):CD001054. [37 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16855956&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Taylor AJ, Cerqueira M, Hodgson JM, Mark D, Min J, O'Gara P, Rubin GD, American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society of Cardiovascular Computed Tomography, American College of Radiology, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, North American Society for Cardiovascular Imaging, Society for Cardiovascular Angiography and Interventions, Society for Cardiovascular Magnetic Resonance, Kramer CM, Berman D, Brown A, Chaudhry FA, Cury RC, Desai MY, Einstein AJ, Gomes AS, Harrington R, Hoffmann U, Khare R, Lesser J, McGann C, Rosenberg A, Schwartz R, Shelton M, Smetana GW, Smith SC Jr. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force [trunc]. J Am Coll Cardiol. 2010 Nov 23;56(22):1864-94. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21087721&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009 Nov 17;151(10):716-26. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19920272&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;U.S. Preventive Services Task Force. Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009 Oct 6;151(7):474-82. [40 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19805770&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Udesky L. The ethics of direct-to-consumer genetic testing. Lancet. 2010 Oct 23;376(9750):1377-8. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20979325&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Wang L, Manson JE, Song Y, Sesso HD. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010 Mar 2;152(5):315-23. [67 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20194238&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Weizman AV, Nguyen GC. Colon cancer screening in 2010: an up-date. Minerva Gastroenterol Dietol. 2010 Jun;56(2):181-8. [62 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20485255&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Weltermann B, Hermann M, Gesenhues S. [Diagnostic screening for cancer and coronary heart disease with radiological and nuclear imaging techniques: early diagnosis at any price?]. Dtsch Med Wochenschr. 2010 Apr;135(16):813-8. [23 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=20391314&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J. Evaluating test strategies for colorectal cancer screening - age to begin, age to stop, and timing of screening intervals: a decision analysis of colorectal cancer screening for the US Preventive Task Force [trunc]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2009. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of evidence supporting the recommendations is not specifically stated.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Appropriate use of screening and diagnostic tests in the low-risk general practice population&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Potential harms of specific tests are provided in the &quot;Major Recommendations&quot; field.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;The information set out in this publication is current at the date of first publication and is intended for use as a guide of a general nature only and may or may not be relevant to particular patients or circumstances. Nor is this publication exhaustive of the subject matter. Persons implementing any recommendations contained in this publication must exercise their own independent skill or judgement or seek appropriate professional advice relevant to their own particular circumstances when so doing. Compliance with any recommendations cannot of itself guarantee discharge of the duty of care owed to patients and others coming into contact with the health professional and the premises from which the health professional operates. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Whilst the text is directed to health professionals possessing appropriate qualifications and skills in ascertaining and discharging their professional (including legal) duties, it is not to be regarded as clinical advice and, in particular, is no substitute for a full examination and consideration of medical history in reaching a diagnosis and treatment based on accepted clinical practices. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Accordingly, the Royal Australian College of General Practitioners and its employees and agents shall have no liability (including without limitation liability by reason of negligence) to any users of the information contained in this publication for any loss or damage (consequential or otherwise), cost or expense incurred or arising by reason of any person using or relying on the information contained in this publication and whether caused by reason of any error, negligent act, omission or misrepresentation in the information. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;These guidelines have not included detailed information on the management of risk factors or early disease (e.g., what medications to use in treating hypertension). Similarly, they have not made recommendations about tertiary prevention (preventing complications in those with established disease). Also, information about prevention of infectious diseases has been limited largely to immunisation and some sexually transmitted infections (STIs). &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;For preventive care to be most effective, it needs to be planned, implemented and evaluated. Planning and engaging in preventive health is increasingly expected by patients. The Royal Australian College of General Practitioners (RACGP) thus provides the Red Book and &lt;em&gt;National guide to inform evidence-based guidelines&lt;/em&gt;, and the Green Book (see the &quot;Availability of Companion Documents&quot; field) to assist in development of programs of implementation. The RACGP is planning to introduce a small set of voluntary clinical indicators to enable practices to monitor their preventive activities.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Resources" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="Staying Healthy" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Patient-centeredness" /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Screening tests of unproven benefit. In: Guidelines for preventive activities in general practice, 8th edition. East Melbourne (Australia): Royal Australian College of General Practitioners; 2012. p. 85-6.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This guideline has been partially adapted from Australian, Canadian, United Kingdom, and/or United States preventive guidelines.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2012" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="Royal Australian College of General Practitioners - Professional Association" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Royal Australian College of General Practitioners&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Red Book Taskforce&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Taskforce Members&lt;/em&gt;: Dr Evan Ackermann (&lt;em&gt;Chair&lt;/em&gt;), Chair, National Standing Committee for Quality Care, RACGP; Professor Mark Harris, Centre for Primary Health Care and Equity, University of New South Wales, National Standing Committee for Quality Care, RACGP; Dr Karyn Alexander, General practitioner, Victoria; Dr Meredith Arcus, General practitioner, Western Australia; Linda Bailey, Project Manager, Red Book Taskforce; Dr John Bennett, Chair, National Standing Committee for e-Health, RACGP; Associate Professor Pauline Chiarelli, School of Health Sciences, University of Newcastle, New South Wales; Professor Chris Del Mar, Faculty of Health Sciences and Medicine, Bond University, Queensland; Professor Jon Emery, School of Primary, Aboriginal and Rural Health Care, The University of Western Australia, National Standing Committee for Research, RACGP; Dr Ben Ewald, School of Medicine and Public Health, University of Newcastle, New South Wales; Dr Dan Ewald, General practitioner, New South Wales, Adjunct Associate Professor, Northern Rivers University Centre for Rural Health, and Clinical Advisor North Coast NSW Medicare Local; Professor Michael Fasher, Adjunct Associate Professor, University of Sydney, and Conjoint Associate Professor, University of Western Sydney, New South Wales; Dr John Furler, Department of General Practice, The University of Melbourne, Victoria; Dr Faline Howes, General practitioner, Tasmania; Dr Caroline Johnson, Department of General Practice, The University of Melbourne, Victoria, National Standing Committee for Quality Care, RACGP; Dr Beres Joyner, General practitioner, Queensland; Associate Professor John Litt, Department of General Practice, Flinders University, South Australia, Deputy Chair, National Standing Committee for Quality Care, RACGP; Professor Danielle Mazza, Department of General Practice, School of Primary Care, Monash University, Victoria, National Standing Committee for Quality Care, RACGP; Professor Dimity Pond, School of Medicine and Public Health, University of Newcastle, New South Wales; Associate Professor Lena Sanci, Department of General Practice, The University of Melbourne, Victoria; Associate Professor Jane Smith, Faculty of Health Sciences and Medicine, Bond University, Queensland; Dr Tania Winzenberg, Deputy Chair, National Standing Committee for Research, RACGP&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Electronic copies: Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://www.racgp.org.au/your-practice/guidelines/redbook/&quot; title=&quot;Royal Australian College of General Practitioners (RACGP) Web site&quot;&gt;Royal Australian College of General Practitioners (RACGP) Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following&amp;nbsp;is available:&lt;/p&gt;&#xD;&#xA;&lt;ul&gt;&#xD;&#xA;    &lt;li&gt;Putting prevention into practice (green book). East Melbourne (Australia): Royal Australian College of General Practitioners; 2006. 104 p. Electronic copies: Available in PDF from the &lt;a href=&quot;http://www.racgp.org.au/your-practice/guidelines/greenbook/&quot;&gt;Royal Australian College of General Practitioners (RACGP) Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None available&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary was completed by ECRI Institute on May 31, 2013.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouse (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
